|
|
Article: Eon Labs Receives Approval for Lisonpril Tablets.
- Article from:
- Business Wire
- Article date:
- July 1, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors
Eon Labs, Inc. (Nasdaq: ELAB) announced today that it received final approval for Lisinopril Tablets, the generic alternative for the hypertension treatment Zestril(R)(a).
Eon Labs approval is for the same strengths as the brand, 2.5mg, 5mg, 10mg, 20mg, 30mg, and 40mg tablets. Shipments of Lisinopril will begin immediately. The approval of Lisinopril tablets is the 10th approval received by Eon Labs in 2002.
Eon Labs is a generic pharmaceutical company specializing in developing, licensing, manufacturing, selling and distributing a broad range of prescription pharmaceutical products. Eon's diverse product line includes over 90 ...